Ligand validation:4DVL

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 4DVL designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4DVL_NAG_B_1109	37%	22%	0.204	0.902	1.61	1.76	4	4	0	0	100%	0.8513
4DVL_NAG_A_1107	28%	17%	0.245	0.899	1.53	2.27	3	7	0	0	100%	0.8013
4DVL_NAG_B_1110	18%	15%	0.232	0.822	1.54	2.41	3	9	0	0	100%	0.8293
4DVL_NAG_A_1106	17%	8%	0.241	0.817	1.69	3.05	3	9	1	0	100%	0.762
4DVL_NAG_B_1111	2%	12%	0.419	0.666	1.88	2.32	4	5	0	0	100%	0.9333
4DW5_NAG_B_1112	69%	39%	0.101	0.914	0.95	1.5	1	3	1	0	100%	0.7213
4DW3_NAG_A_1106	67%	43%	0.129	0.939	1.14	1.1	-	1	0	0	100%	0.762
4DW4_NAG_A_1108	63%	81%	0.123	0.917	0.31	0.51	-	-	0	0	100%	0.8013
4DWC_NAG_B_1108	62%	71%	0.139	0.933	0.26	0.82	-	1	0	0	100%	0.7373
4DVN_NAG_B_1106	60%	72%	0.132	0.918	0.23	0.83	-	1	0	0	100%	0.7653
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.